Impact of trough plasma imatinib levels on patients with suboptimal responses after treatment with standard dose of imatinib in chronic-phase chronic myelogenous leukemia
JIANG Hao
CHEN Shan-shan
HUANG Xiao-jun
QIN Ya-zhen
LAI Yue-yun
QIN Xiao-ying
JIANG Bin
Machine-generated Keywords：
Publication Date：2012-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)